{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:03:56Z","timestamp":1768745036055,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81273354"],"award-info":[{"award-number":["81273354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NSFC for International Cooperation","award":["81420108027"],"award-info":[{"award-number":["81420108027"]}]},{"name":"NSFC for International Cooperation","award":["30910103908"],"award-info":[{"award-number":["30910103908"]}]},{"name":"Higher Education of China","award":["20110131130005"],"award-info":[{"award-number":["20110131130005"]}]},{"name":"Ministry of Science and Technology of China","award":["2003DF000033"],"award-info":[{"award-number":["2003DF000033"]}]},{"name":"Science and Technology Development Project of Shandong Province","award":["2014GSF118175"],"award-info":[{"award-number":["2014GSF118175"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ejmech.2015.11.039","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T13:45:56Z","timestamp":1450791956000},"page":"294-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket"],"prefix":"10.1016","volume":"109","author":[{"given":"Jiapei","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boshi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Daelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.11.039_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1098-1128(200003)20:2<129::AID-MED2>3.0.CO;2-A","article-title":"The HIV-1 reverse transcription (RT) process as target for rt inhibitors","volume":"20","author":"Jonckheere","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2015.11.039_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-4755-10-23","article-title":"Global report: UNAIDS report on the global AIDS epidemic 2013","volume":"10","author":"Yisma","year":"2014","journal-title":"Reprod. Health"},{"key":"10.1016\/j.ejmech.2015.11.039_bib3","first-page":"128","article-title":"Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"7","author":"Boone","year":"2006","journal-title":"Curr. Opin. Investig. Drugs (London, Engl. 2000)"},{"key":"10.1016\/j.ejmech.2015.11.039_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/1381612024607207","article-title":"Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives","volume":"8","author":"Campiani","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.11.039_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJM199803263381310","article-title":"Progress and problems in the fight against AIDS","volume":"338","author":"Hirschel","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2015.11.039_bib6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2174\/092986708784221467","article-title":"The current status of the NNRTI family of antiretrovirals used in the HAART regime against HIV infection","volume":"15","author":"Martins","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.37.5.1127","article-title":"U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication","volume":"37","author":"Dueweke","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2015.11.039_bib8","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1021\/jm030558s","volume":"47","author":"Das","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib9","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1128\/AAC.39.12.2602","article-title":"L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase","volume":"39","author":"Young","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2015.11.039_bib10","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1073\/pnas.82.20.7096","article-title":"3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy-associated virus in\u00a0vitro","volume":"82","author":"Mitsuya","year":"1985","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2015.11.039_bib11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/AAC.00986-09","article-title":"TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1","volume":"54","author":"Azijn","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2015.11.039_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/092986711794839142","article-title":"Recent advances in DAPYs and related analogues as HIV-1 NNRTIs","volume":"18","author":"Chen","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib13","article-title":"Anti-hiv drug discovery and development: current innovations and future trends","author":"Zhan","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib14","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/jm1002233","article-title":"Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design","volume":"53","author":"Lansdon","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cbdd.12520","article-title":"Synthesis and preliminary antiviral activities of Piperidine-substituted purines against HIV and Influenza A\/H1N1 infections","volume":"86","author":"Kang","year":"2015","journal-title":"Chem. Biol. drug Des."},{"key":"10.1016\/j.ejmech.2015.11.039_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejmech.2015.08.007","article-title":"Pyrimidine sulfonylacetanilides with improved potency against key mutant viruses of HIV-1 by specific targeting of a highly conserved residue","volume":"102","author":"Wan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejmech.2015.02.022","article-title":"Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines","volume":"93","author":"Huang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ejmech.2015.01.042","article-title":"Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches","volume":"92","author":"Huang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib19","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1021\/jm200990c","article-title":"Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms","volume":"55","author":"Li","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib20","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/jm00061a022","article-title":"5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase","volume":"36","author":"Williams","year":"1993","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bmcl.2007.11.085","article-title":"Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)","volume":"18","author":"Zhao","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.11.039_bib22","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/jm1002233","article-title":"Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design","volume":"53","author":"Lansdon","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib23","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1021\/jm101614j","article-title":"Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide","volume":"54","author":"La Regina","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/jm040854k","volume":"48","author":"Ragno","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib25","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1021\/jm0512490","article-title":"Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide","volume":"49","author":"Ragno","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib26","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1021\/jm070488f","article-title":"Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity","volume":"50","author":"Regina","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib27","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/jm801470b","article-title":"Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus","volume":"52","author":"Piscitelli","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib28","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1021\/jm300477h","article-title":"New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"55","author":"La Regina","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2014.04.027","article-title":"New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"80","author":"Famiglini","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejmech.2013.04.052","article-title":"Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"65","author":"Yang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib31","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1016\/j.bmcl.2013.10.059","article-title":"Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"23","author":"Chen","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.11.039_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmech.2014.09.054","article-title":"Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization","volume":"87","author":"Liu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/cbdd.12471","article-title":"Design, synthesis, and anti-HIV evaluation of novel triazine derivatives targeting the entrance channel of the NNRTI binding pocket","volume":"86","author":"Chen","year":"2015","journal-title":"Chem. Biol. drug Des."},{"key":"10.1016\/j.ejmech.2015.11.039_bib34","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1248\/cpb.34.3658","volume":"34","author":"Kaneko","year":"1986","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2015.11.039_bib35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/op800004q","article-title":"Regioselective addition of Mesitol to a 2,4-Dichloropyridine","volume":"12","author":"Ruggeri","year":"2008","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2015.11.039_bib36","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1021\/jo00051a062","article-title":"Synthesis of 7-azaindole and 7-azaoxindole derivatives through a palladium-catalyzed cross-coupling reaction","volume":"57","author":"Kumar","year":"1992","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib37","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1002\/anie.200601612","article-title":"Monodentate phosphines provide highly active catalysts for Pd-catalyzed C-N bond-forming reactions of heteroaromatic halides\/amines and (H)N-heterocycles","volume":"45","author":"Anderson","year":"2006","journal-title":"Angewandte Chemie Int. ed. Engl."},{"key":"10.1016\/j.ejmech.2015.11.039_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0166-0934(93)90054-U","article-title":"Poly A-linked colorimetric microtiter plate assay for HIV reverse transcriptase","volume":"44","author":"Suzuki","year":"1993","journal-title":"J.\u00a0virological methods"},{"key":"10.1016\/j.ejmech.2015.11.039_bib39","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1016\/j.ejmech.2011.08.011","article-title":"Arylazolylthioacetanilide. Part 8: design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors","volume":"46","author":"Zhan","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J.\u00a0virological methods"},{"key":"10.1016\/j.ejmech.2015.11.039_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nprot.2007.517","article-title":"Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later","volume":"3","author":"Pannecouque","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2015.11.039_bib42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6200935","article-title":"Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS","volume":"224","author":"Popovic","year":"1984","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.ejmech.2015.11.039_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.2425430","article-title":"Isolation of a new human retrovirus from West African patients with AIDS","volume":"233","author":"Clavel","year":"1986","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.ejmech.2015.11.039_bib44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejmech.2014.04.036","article-title":"Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach","volume":"80","author":"Li","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10822-011-9533-y","article-title":"Surflex-Dock: docking benchmarks and real-world application","volume":"26","author":"Spitzer","year":"2012","journal-title":"J.\u00a0Comp. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2015.11.039_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10822-007-9114-2","article-title":"Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search","volume":"21","author":"Jain","year":"2007","journal-title":"J.\u00a0Comp. Aided Mol. Des."},{"issue":"4","key":"10.1016\/j.ejmech.2015.11.039_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/jm020406h","article-title":"Surflex: Fully Automatic flexible molecular docking using a molecular similarity-based search Engine","volume":"46","author":"Jain","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.11.039_bib48","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.M601074200","article-title":"Alkylamides from Echinacea are a new class of cannabinomimetics: Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects","volume":"281","author":"Raduner","year":"2006","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415303755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415303755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T17:35:19Z","timestamp":1567445719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415303755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":48,"alternative-id":["S0223523415303755"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.11.039","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}